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Abstract Thy-1 (CD90) is an adhesion molecule induced
in Wbroblast populations associated with wound healing and
Wbrosis. In this study the question whether Thy-1-gene-
expression can be induced in hepatic stellate cells (HSC) in
vivo, under conditions of liver injury or liver regeneration
was addressed. Acute and chronic rat liver injury was
induced by the administration of CCl4. For comparison, cir-
rhotic human liver, and rat 67% partial hepatectomy (PH)
was studied as well. Thy-1-gene-expression was examined
also in isolated human liver myoWbroblasts. Thy-1-mRNA
expression was signiWcantly upregulated in chronic liver
injury. Thy-1+ cells were detected in the periportal area of
rat liver specimens in normal-, injured- and regenerative-
conditions. In chronic human and rat liver injury, Thy-1+
cells were located predominantly in scar tissue. In the peri-
central necrotic zone after CCl4-treatment, no induction of
Thy-1 was found. Gremlin and Thy-1 showed comparable
localization in the periportal areas. Thy-1 was not detected
in either normal or capillarized sinusoids, in isolated rat
HSC, and was neither inducible by inXammatory cytokines
in isolated HSC, nor upregulated in treated myoWbroblasts.
Based upon these data Thy-1 is not a marker of “activated”
sinusoidal HSC, but it is a marker of “activated”
(myo)Wbroblasts found in portal areas and in scar tissue.
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Introduction
Several Wbroblastic cell types have been described in the
liver (Johnson et al. 1992). Typical hepatic stellate cells
(HSC), transitional cells [intermediate between HSC and
myoWbroblasts (MF)] and MF have been reported to be
present in the perisinusoidal space of Disse. Portal tracts
are reported to harbor portal (myo)Wbroblasts. In addition,
periductal (myo)Wbroblasts and vascular smooth muscle
cells residing in the walls of portal vein branches and portal
arteries have been thought to constitute distinct subpopula-
tions of mesenchymal cells in the portal tract (Cassiman
and Roskams 2002). Another subpopulation of liver Wbro-
blastic cells are the MF located around the centrolobular
vein: the so-called second-layer cells (Cassiman and Rosk-
ams 2002). These second-layer cells were suggested to pro-
liferate in the livers of alcohol-fed baboons, causing typical
‘alcoholic type’ pericentral Wbrosis (Nakano and Lieber
1982). Finally, (myo)Wbroblasts residing in the liver cap-
sule (Glisson’s capsule) form a potential source of extracel-
lular matrix in the liver (Cassiman and Roskams 2002;
Ramadori and Saile 2004; Blanc et al. 2005; Guyot et al.
2006).
Hepatic stellate cells (HSC) (Ito cells, lipocytes) are the
pericytes of the liver sinusoid (Anonymus 1996; Cassiman
et al. 2002; Ramadori ans Saile 2004). Their main physio-
logical function is vitamin A (retinoid) storage (Ramadori
et al. 1990; Cassiman and Roskams 2002; Ramadori and
Saile 2002). In liver injury HSC (of the liver sinusoids)
transform from a quiescent to an “activated” state (Ramadori
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2002). HSC were identiWed in tissue sections by detection
of the intermediate Wlament protein Desmin (Johnson et al.
1992).
MyoWbroblasts (MF) have been reported as being absent
from normal liver, and produced as a result of activation of
precursor cells like portal Wbroblasts (Guyot et al. 2006).
Studies have shown that non-parenchymal cells express
-smooth muscle actin (SMA), similar to that of myoWbro-
blasts in healing wounds in Wbrotic rat and human liver
(Johnson et al. 1992; Guyot et al. 2006). These cells are
morphologically similar to Desmin-positive HSC. The pre-
cise relationship between these various cell populations has
not been fully determined (Johnson et al. 1992).
IdentiWcation of the diVerent mesenchymal cells in the
damaged liver by means of the in vitro determined pheno-
typical and functional markers, and of their quantitative
contribution to the development of liver Wbrosis has been
diYcult (Ramadori and Saile 2002). The diVerentiation of
the “activated” hepatic stellate cells from myoWbroblasts is
only possible through their localization within the hepatic
lobule. However, in some locations, as for example the
sinusoids several subpopulations of liver mesenchymal
cells may be present under various conditions. A com-
monly used phenotypic marker, SMA, is expressed in acti-
vated hepatic stellate cells, in liver myoWbroblasts (MF)
and in smooth muscle cells of the portal and the central ves-
sels (Knittel et al. 1999a; Cassiman and Roskams 2002;
Ramadori and Saile 2004). In contrast, Fibulin-2 and Grem-
lin (Ogawa et al. 2007) have been described as speciWc
markers for MF, and diVerentiates them from “activated”
HSC (aHSC). However, as secreted proteins (Ogawa et al.
2007), they can conWrm the identiWcation of myoWbroblasts
in vitro, but less clearly in vivo (Knittel et al. 1999a). In
fact, in vitro studies have shown that, Fibulin-2- or Grem-
lin-synthesis is absent in HSC, but it is present in MF popu-
lations. Furthermore, in vitro studies have classiWed SMA/
Fibulin-2/IL-6 positive cells as MF (Knittel et al. 1999a;
Ramadori and Saile 2002; Saile et al. 2002). Functional in
vitro studies suggest that cultured rat HSC and MF diVer
not only in expressing diVerent markers, but also in
expressing diVerent cytokines and growth factors (Schirm-
acher et al. 1992; Tiggelman et al. 1995; Knittel et al.
1999a), as well as their diVerent responses to various cyto-
kines and growth factors (Tiggelman et al. 1995; Saile et al.
2002, 2004. Moreover, they also diVer in apoptotic and pro-
liferation characteristics, and in cell cycle regulation (Saile
et al. 2002, 2004; Dudas et al. 2003; Ogawa et al. 2007).
Although, several functional diVerences have been
described in liver mesenchymal cells in vitro, in lack of
reliable identiWcation marker of those cells in vivo, it was
diYcult the coupling of the in vitro data with the in vivo
models and with the human cirrhosis.
In 2006 the cell surface glycoprotein: Thy-1 was identi-
Wed as a speciWc marker of liver myoWbroblasts (Mansuro-
glu et al. 2006). Thy-1 is a glycophosphatidylinositol
(GPI)-linked outer membrane leaXet glycoprotein, which
belongs to a subset of haematopoetic stem cell markers. It
was Wrst described in 1964, and subsequently isolated, puri-
Wed, and characterized in rodents (Reif and Allen 1964).
Koumas et al. (2003) reported that human Wbroblasts are
heterogeneous with respect to cell surface Thy-1 expression
and that Wbroblasts could be segregated into Thy-1+ and
Thy-1- subsets resulting with distinct functions.
Recent gene expression analysis of isolated liver cell
populations in our laboratory has demonstrated that signiW-
cant Thy-1 expression can be recognized in cultured rat
liver myoWbroblasts (SMA-and Fibulin-2-positive). In con-
trast, Thy-1-gene-expression is not found in freshly iso-
lated, or in qHSC or aHSC. At the levels of mRNA and
protein subcultured rat liver myoWbroblasts represented one
homogenous Thy-1-positive cell population, similar to that
of myoWbroblasts in other tissues (Dudas et al. 2007).
Based on these data, Thy-1 expression might be a cell sur-
face marker capable of distinguishing HSC and hepatic
myoWbroblasts populations in vivo.
In a previous study it was reported that Thy-1 expression
is induced in Wbroblast populations associated with wound
healing and Wbrosis (Pei et al. 2004). In the present study
the question whether Thy-1-gene-expression becomes
detectable in hepatic stellate cells (HSC) in vivo, under
conditions of liver injury or liver regeneration was addressed
utilizing CCl4-induced rat liver injury and regeneration,
or partial hepatectomy of the rat liver, and examination of
human liver cirrhosis. In all three models the expression
of alpha smooth muscle actin was detectable in “activated
HSC” of the liver sinusoids. In addition the gene expres-
sion of established markers of liver myoWbroblasts (SMA,
Fibulin-2, Gremlin) (Knittel et al. 1999a; Ogawa et al.
2007) was compared to that of Thy-1.
Materials and methods
Materials
All chemicals were purchased from Merck (Darmstadt,
Germany), Applichem (Darmstadt, Germany) or Sigma
(Steinheim, Germany). The materials utilized for biochemi-
cal and immunohistochemical procedures are listed in the
appropriate sections.
Liver specimens
One histologically normal and two cirrhotic liver specimens
were received from the Department of Gastroenteropathology123
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consent was obtained from each patient included in the
study and the study protocol conWrmed to the ethical guide-
lines of the 1975 Declaration of Helsinki as reXected in
a priori approval by the institution’s human local ethics
committee. Three-human liver samples were used for
immunohistochemical analysis.
Animals
Wistar rats were purchased from Harlan Winkelmann (Bor-
chen, Germany), and received humane care in compliance
with the institutions’ and the National Institutes of Health
guidelines.
Animal models
The following rat models were used for examination of rat
liver damage, and regeneration: CCl4-induced acute liver
injury (by a single CCl4-administration) and chronic liver
injury with regeneration (after sequentially repeated CCl4-
administration up to 17 weeks). In addition rat liver after
partial hepatectomy (PH) was utilized as an example of
regenerating liver. Sham operations were performed in the
controls of the PH-treated animals (Dudas et al. 2006).
Male and female Wistar rats weighing approximately
200 g were given CCl4/corn oil solution (50%, v/v) orally
as described earlier (Dudas et al. 2006). Acute liver dam-
age was induced by administration of a single dose of
150 l CCl4/100 g body weight; control animals were
given corn oil only (Neubauer et al. 1998). Each two ani-
mals were sacriWced 3, 6, 9, 12, 24, 48 and 72 h after treat-
ment. The liver was removed, and snap-frozen in liquid
nitrogen. For the induction of liver Wbrosis, chronic dam-
age and regeneration: animals (male and female Wistar
rats weighing approximately 200 g, were exposed to oral
application of CCl4 once a week for a period of 12–
17 weeks. At the end of the treatment, the liver was
removed and snap-frozen in liquid nitrogen. The frozen
specimens were used for RNA isolation and immunohisto-
chemical studies.
Isolation of rat HSC, rat liver myoWbroblasts, human liver 
myoWbroblasts and culture conditions
Hepatic stellate cells and liver myoWbroblasts were isolated
by sequential in situ perfusion with collagenase and
pronase as described previously (Knittel et al. 1999a;
Neubauer et al. 1996). Yields of 40 £ 106 HSC in mean
were obtained per rat. Purity was >85% in freshly isolated
cells. Cells were plated at a density of 30,000 cells/cm2 and
cultured in Dulbeccos modiWed Eagles medium (DMEM,
PAA, Linz, Austria) supplemented with 15% fetal calf
serum (FCS), 100 U/ml penicillin, 100 g/ml streptomycin
and 1% L-glutamine. The culture medium was replaced
2 days after plating and then every second day. The cul-
tured cells were maintained at 37°C in a 5% CO2 atmo-
sphere with 100% humidity.
Rat liver myoWbroblasts were isolated as described pre-
viously (Novosyadlyy et al. 2004; Dudas et al. 2007).
Human liver myoWbroblasts were isolated as described
recently by Müller et al. (2007). The rat and human liver
myoWbroblasts were cultured as described above.
Immunostaining of cryosections and isolated liver cells
Five-micrometers thick sections were prepared with a cryo-
stat (Reichert Jung, Wetzlar, Germany) for each model and
for human liver samples. For the immuncytochemical
analyses, human hepatic myoWbroblasts were cultured on
chambered slides (Nunc, Roskilde Denmark). Sections were
air-dried, chambered slides were washed with 1£ PBS
(Biochrom, Berlin, Germany) and used for immunohisto-
or cyto-chemical studies with 10 minutes of acetone Wxation
at room temperature. After blocking with 1% bovine serum
albumin (Serva, Heidelberg, Germany) and 10% goat
serum (DAKO, Glostrup, Denmark) in PBS (Biochrom) for
1 h at room temperature, two primary antibodies were
added simultaneously, or one primary antibody was incu-
bated on the sections, overnight at 4°C. The primary anti-
bodies used were: rabbit polyclonal: anti-Desmin (1:100,
Acris Antibodies, Hiddenhausen, Germany) anti-Gremlin
(1:200, Imgenex, San Diego, CA, USA) rabbit monoclo-
nal: anti-SMA (1:100, Epitomics, Burlingame, CA, USA);
mouse monoclonal: anti-Desmin (1:100; DAKO), anti-rat-
Thy-1 (1:50; Clone: OX-7, Pharmingen, San Diego, CA,
USA), anti-human-Thy-1 (1:50; Pharmingen) and anti-
SMA (Sigma, Steinheim, Germany) (1:37.5, Upstate, Lake
Placid, NY, USA). Rabbit mono- and poly-clonal antibod-
ies were realized with Alexa 555-conjugated goat-anti-rab-
bit secondary antibody (Molecular Probes, Leiden, the
Netherlands), diluted 1:400 in PBS. Mouse monoclonal
antibodies were visualized with Alexa 488- or Alexa 555-
conjugated secondary goat-anti-mouse antibody (Molecular
Probes) diluted 1:200 in PBS. The immunostained sections
were examined with Xuorescent microscopy after counter-
staining with DAPI (Molecular Probes). The stainings were
analyzed with an epiXuorescent microscope (Axiovert
200M, with Apotome function) (Zeiss, Jena, Germany).
The microphotographs were obtained using the Axiovision
4.2 and 4.5 softwares of Zeiss.
Negative control immunostainings were performed, both
by omission of the primary antibody and usage of isotype-
speciWc control immunoglobulins, as well as usage of anti-
bodies directed against antigens not expressed in rat liver
(Dudas et al. 2006, 2007).123
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Quantitation of Thy-1-positive cells detected by immuno-
histochemistry was performed by counting of positive cells
(positive-stained particles) in ten independent Welds on sec-
tions of normal rat liver and of diVerent time points after
acute and chronic CCl4-induced rat liver injury. The analy-
sis of positive reaction was performed by the application of
the Image J software (Wayne Rasband, NH, USA). The
average and standard deviation of the counted positive par-
ticles were displayed graphically, and were also analyzed
related to the counted particles in the control rat liver. The
quantitation of Thy-1+ immunohistochemical reaction was
correlated with the Thy-1 mRNA expression by correlation
analysis (Graphpad Prism software).
RNA isolation and real-time RT-PCR
Total RNA was isolated after homogenization in guanidi-
nium-isothiocyanate (Invitrogen, Carlsbad, CA, USA)
from isolated cells after culture and from livers of normal,
acute and chronic CCl4-treated, sham-operated or partial
hepatectomized rats, followed by CsCl (Invitrogen) gradi-
ent ultra-centrifugation (Chirgwin et al. 1979). Reverse
transcription of RNA samples was performed with MMLV
reverse transcriptase (Invitrogen), according to the instruc-
tions of the manufacturer. Real-time PCR analysis of
reverse transcripts (cDNAs) was performed with the Abi
Prism Sequence Detection System 7000 of Applied Bio-
systems (Foster City, CA, USA) following the manufac-
turer’s instructions, using Sybr-green reaction master mix
(Invitrogen) and primers described in previous studies
(Gremlin (Ogawa et al. 2007), SMA (Dudas et al. 2007),
or in Table 1. Primers were synthesized by MWG Biotech
(Ebersberg, Germany) or by Invitrogen. The quantity of
the PCR products of the genes of interest was determined
based on the threshold PCR cycle-values (Ct value), fol-
lowing the instructions of Applied Biosystems and nor-
malized relative the quantities of the endogenous control
(Ubiquitin C) PCR product (Raddatz et al. 2005). Ubiqui-
tin C expression was not aVected by any of the treatments
used in the animal models. The normalized Thy-1, Fibulin-
2, Desmin, Gremlin and SMA PCR-product quantities of
treated animals were compared to the values of control
animals, and the relative expression was plotted against
the observation time (Dudas et al. 2006, 2007). In all
cases, two or more animal series were analyzed in dupli-
cates. Statistical signiWcance (P < 0.05) was tested with
Student’s t-test, and One-way Analysis of Variance
(ANOVA).
Results
Thy-1 in normal rat liver
In normal rat liver, sparse periportal Thy-1-expression was
detected adjacent to the wall of the portal vein, arteries, and
bile ducts. No speciWc Thy-1-reaction was detected within
the hepatic parenchyma (Dudas et al. 2007).
Thy-1+ cells were located within the stroma of portal
tracts found adjacent to the wall of the portal vein, and of
the hepatic artery. Thy-1+ cells typically showed a peripor-
tal localization (Fig. 1a). SMA was present in smooth mus-
cle cells of the media of portal tract vessels (Dudas et al.
2007), and in cells lining the hepatic vein radicles (Johnson
et al. 1992). Gremlin located in the wall of portal arteries
and within the stroma of portal tracts. Thy-1 directly did
not co-localize with Gremlin, rather the two markers
showed adjacent localization in the portal tract (Fig. 1a).
In the normal rat liver: Thy-1, Gremlin and Fibulin-2
mRNA expression was low, while SMA and Desmin
expression was higher.
Thy-1 in CCl4-induced acute and chronic liver injury
Utilizing the CCl4 model characterized by pericentral hepa-
tocellular necrosis, inXammation, and regeneration result-
ing in a complete restitution, the distribution of Thy-1
relative to the other markers was analyzed. Livers obtained
from CCl4-treated animals were studied from 3 to 72 h fol-
lowing the administration of the CCl4.
Table 1 Primers used for quantitative real-time RT-PCR




Rat Thy-1 5-TGA ACC CAG TCA TCA GCA T-3 5-CAG TCG AAG GTT CTG GTT CAC C-3 106 47–153
Rat Fibulin-2 5-AGT CTG CCC AGG TAT CTC CCA A-3 5-TCG CCA ATA ACG CGA CAC A-3 102 2237–2339
Rat Ubiquitin C 5-CAC CAA GAA GGT CAA ACA GGA A-3 5-AAG ACA CCT CCC CAT CAA ACC-3 101 2379–2480
Rat Desmin 5-GTG AAG ATG GCC TTG GAT GT-3 5-CGG GTC TCA ATG GTC TTG AT-3 182 1248–1430
Rat Gremlin 5-GAT TGG TGC AAA ACT CAG CCC-3 5-AAG GAG TTG CAC TGG CCG TAA-3 101 413–514
Human Thy-1 5-CTA GTG GAC CAG AGC CTT CG-3 5-TGG AGT GCA CAC GTG TAG GT-3 236 141–376123
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expression of Thy-1, Desmin and SMA was increased sig-
niWcantly after 48 h (P < 0.01, with one-way ANOVA,
Fig. 2a). Thy-1 was increased 1.85 § 0.04-fold while
SMA: 11.95 § 3.02-fold (Supplementary Table S1). The
increase of Desmin was 2.69 § 0.87-fold. The Fibulin-2-
and Gremlin-gene expression did not change over time
(Fig. 2a).
In the chronic CCl4-treated rats Thy-1-, SMA-, Desmin-
Gremlin- and Fibulin-2 expression increased signiWcantly
in comparison to that of control animals (Students t test,
P< 0.01, Supplementary Table S1).
In the CCl4 injury model Thy-1+ cells were detectable
within the cell-rich stroma adjacent to the walls of peripor-
tal arteries and veins (Fig. 3a). The SMA+ cells were pres-
ent in the vessel walls of portal areas, several of them
expressing also Thy-1. Forty-eight hours after CCl4-treat-
ment the number of Thy-1+ cells increased (Fig. 3a, b), and
the positive cells still remained within the portal areas. In
this location in more cells Thy-1 co-localized with SMA
(Fig. 3 a, arrows). These cells were identiWed as Thy-1+
Wbroblasts (Fig. 3a).
After repeated CCl4-administration the Thy-1+ reaction
remained primarily in the periportal area, similar to that of
SMA, being localized within the Wbrotic septa (Fig. 3a). A
diVuse SMA+ reaction was found in the sinusoids of the
regenerating nodules. The SMA+ -reaction did not show
signiWcant sinusoidal co-localization with Thy-1 (Fig. 3a).
Similarly to the mRNA expression, the Thy-1-immun-
histochemical reaction increased at later time points after
CCl4-administration, and in chronic rat liver injury
(Fig. 3b). The immunohistochemical changes correlated
well with the gene expression data (the correlation coeY-
cient was 0.94, Supplementary Table S1).
Since Thy-1 has been identiWed on the endothelium of
newly formed blood vessels (Lee et al. 1998), the immuno-
histochemical localization of Thy-1 with that of von Wille-
brand-factor (vWF) was examined (Fig. 4). Thy-1 was
expressed only in the periportal areas, and was not found in
the acinar zone 3 after acute liver damage. In contrast, vWF
labeled the central vein, and manifested a spot-like reaction
in acinar zone 3 48 h after CCl4 administration, but no Thy-
1+ reaction was detected in this zone (Fig. 4b). Co-localiza-
tion of Thy-1 and vWF was limited, therefore with Thy-1+
expression seen only adjacent to the walls of vWF+ vessels
in both acute and chronic liver injury due to CCl4.
The immunolocalization of Thy-1 was compared with a
recently described marker of liver myoWbroblasts: Gremlin.
Gremlin was found in the wall of the central vein, and it co-
localized with Thy-1 in rare microvessels (Fig. 5). Thy-1+
cells were identiWed in the periportal areas next to the
Gremlin+ cells. In chronic liver injury, Thy-1 and Gremlin
were found in the Wbrotic septa and the regenerating nod-
ules. In the Wbrotic septa co-localization of these two mark-
ers was demonstrated.
Thy-1 in the rat partial hepatectomy liver regeneration 
model
In regenerating rat liver [after partial hepatectomy (PH)],
Thy-1, Fibulin-2 and Gremlin gene expression did not
increase (P > 0.05, one-way ANOVA, Fig. 2b, Supplemen-
tary Table S1). SMA- and Desmin-gene-expression signiW-
cantly increased 8–24 h after PH (P < 0.05, with one-way
ANOVA) (Fig. 2b). After Sham operation, no upregulation
of the genes investigated was observed (Fig. 2b).
Several hours to several days after partial hepatectomy
(PH), Thy-1 showed a periportal localization similar to that
seen in the normal liver. Thy-1+ cells were found adjacent
to the portal vessels, and co-localized with SMA or Desmin
(Fig. 6a, b). A Wne-structured SMA+ immunohistochemical
reaction was demonstrated perisinusoidally in the liver
Fig. 1 Thy-1 and Gremlin detection in normal rat liver, Thy-1 and
SMA in human liver. ImmunoXuorescent staining of Thy-1 (green) (a,
b) and Gremlin (a) (red) or SMA (b) in sections of the normal rat (a)
and human (b) liver. Arrows represent periportal co-localization
between Thy-1 and SMA in the normal human liver. a £200; b £100
original magniWcation. The blue staining with DAPI represents the nu-
clei. a Bar 50 m. b Bar 100 m123
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PH the SMA+ reaction was reduced signiWcantly, following
the mRNA expression-pattern (Figs. 2b, 6b,).
Desmin showed positive reaction in the stromal cells of
the periportal area, in the wall of the central vein and in the
liver sinusoids. The sinusoidal reaction increased 16–24 h
after PH, and after 48 h it was reduced to normal level.
Thy-1 co-localized with Desmin in the stromal cells of the
periportal areas and in the wall of the portal vessels at each
time points studied after PH. The Thy-1+ sinusoidal reac-
tion was diVuse, and it did not co-localize with Desmin
(Fig. 6).
Thy-1 in the normal human liver and human cirrhosis
In normal human liver Thy-1+ cells were located within the
periportal tract, and were more numerous than in the rat liver
(Fig. 1b). This Wnding was conWrmed by real-time RT-PCR.
Fig. 2 Analysis of Thy-1-gene-
expression in comparison with 
known markers of liver mesen-
chymal cells in CCl4-induced 
acute rat liver injury and in par-
tial hepatectomy induced liver 
regeneration. a Thy-1, Fibulin-2, 
Desmin, Gremlin and SMA rela-
tive expressions in livers of sin-
gle CCl4-treated rats, at 
indicated time points after treat-
ment, related to corn oil-treated 
controls. The graphs plotted rep-
resent two independent treat-
ment series, in duplicates. 
Asterisks represent signiWcant 
upregulation, at level of 
P < 0.05. The expression levels 
of the treated rats were com-
pared with controls using one-
way ANOVA. b SMA, Desmin, 
Thy-1, Fibulin-2 and Gremlin 
relative expressions in livers of 
partial hepatectomised rats, at 
indicated time points after PH, 
related to Sham-operated rats. 
The graphs plotted represent two 
independent treatment series, in 
duplicates. Asterisks: signiWcant 
upregulation, at level of 
P < 0.05. The expression levels 
of the treated rats were com-
pared with controls using Stu-
dents t test123
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normal rat liver was 31.05, while in the normal (non-cir-
rhotic) human liver it was 29.8. The immunohistochemical
reaction of Thy-1 co-localized with SMA in the periportal
area (Fig. 1b). In human cirrhosis Thy-1-gene-expression
increased as compared to the normal human liver. Thy-1+
cells were predominantly located in the cirrhotic septa, and
they appeared to be invading the regenerating nodules
(Fig. 7). Thy-1 co-localized in more cells with SMA and
Desmin within the scar tissue of the cirrhotic septa (Fig. 7a,
b, arrows). In the scar tissue and adjacent to the septa Thy-1
rarely co-localized with von Willebrand-factor (vWF)
(Fig. 7a, b). In the sinusoids adjacent to the scar tissue rare
scattered co-localization between Lyve-1 and Thy-1 was
detected (Fig. 7c). Von Willebrand-factor and Lyve-1 are
endothelial markers (Mouta Carreira et al. 2001). Both
Desmin and SMA labeled Thy-1- sinusoidal cells (Fig. 7a).
Thy-1 expression in human liver myoWbroblasts
Rat liver myoWbroblasts showed a homogeneous Thy-1+
population, which we reported previously (Mansuroglu
et al. 2006; Dudas et al. 2007). As is the case with isolated
rat liver myoWbroblasts, isolated human liver myoWbro-
blasts are Thy-1+/SMA+, but only minimally express
Desmin (Fig. 8).
Discussion
Multiple investigations have reported (Ogawa et al. 2007)
that the conventional qHSC-enriched fraction contains two
types of cells, true qHSCs as the major cell type and a
minor fraction of MFs (Table 2). The former cells lack
Fig. 3 Immunolocalization of Thy-1 and SMA in CCl4-induced acute
and chronic rat liver injury. ImmunoXuorescent stainings of Thy-1
(green) and SMA (red) after acute liver injury (12, 48 h) (a) induced
by a single administration of CCl4 and after chronic rat liver injury af-
ter 17 weeks of treatment (induced by weekly repeated administrations
of CCl4 (a). The Thy-1 and SMA immunoXuorescent labelings were
compared on sequential sections. Periportal co-localizations are indi-
cated by arrows. The blue staining with DAPI represents the nuclei
(£100 original magniWcation, bars 100 m). Quantitative analysis of
Thy-1 immunohistochemical reaction (positively stained particles) in
acute and chronic rat liver injury due to CCl4-administration (b)
Fig. 4 Immunolocalization of Thy-1 and vWF in CCl4-induced acute
and chronic liver injury. ImmunoXuorescent stainings of Thy-1 (green)
and vWF (red) after acute liver injury [6 h (a), 48 h (b) after a single
administration of CCl4], in the pericentral area (left panels) and in the
periportal area (right panels). ImmunoXuorescent stainings of Thy-1
(green) and vWF (red) after chronic rat liver injury [17 weeks after
weekly repeated administrations of CCl4 (c)]. Co-localization of the
two markers was labeled by arrows and shown magniWed in the right
panel. The blue staining with DAPI represents the nuclei (£200 origi-
nal magniWcation, bars 100 m)123
122 Histochem Cell Biol (2009) 131:115–127growth ability and spontaneously undergo activation
(induction of SMA expression) and, as recently described,
to terminal diVerentiation characterized by expression of a
large panel of late vascular smooth muscle cell markers
(Wirz et al. 2008) and manifested by the spontaneous Fas-
mediated apoptosis (Saile et al. 2002). Importantly, these
same investigators have (Ogawa et al. 2007; Saile et al.
2002; Dudas et al. 2003), clearly demonstrated that the
minor cell population, MFs, but not aHSCs, have replica-
tive activity (Table 2). At 7 days in culture aHSC expressed
Desmin, P100, and Alpha-2-Macroglobulin, MF expressed
Fibulin-2, but not P100, and Alpha-2 Macroglobulin (Knit-
tel et al. 1999a; Ogawa et al. 2007, Table 2).
In this study it was analyzed if Thy-1 was induced in
activated (SMA expressing) hepatic stellate cells within the
liver sinusoid. The experiments were performed to test the
hypothesis as to whether in vivo induction of SMA-gene-
expression, which is considered as a marker of activation is
always accompanied by induction of Thy-1-gene-expres-
sion also in hepatic stellate cells, which is considered as a
population of (myo)Wbroblastic cells.
HSC are mainly present in the hepatic parenchyma and
at the scar–parenchymal interface. MFs are the principal
cells located within the scar tissue (Knittel et al. 1999b).
Thy-1 expression has the potential to distinguish between
aHSC and rMF in vitro (Mansuroglu et al. 2006; Dudas
et al. 2007). In the current study we found that Thy-1-gene-
expression is not induced in hepatic stellate cells lining the
liver sinusoids in vivo, which are in response to liver injury
and partial hepatectomy become SMA-positive (Table 2).
In addition, in human cirrhosis Thy-1+ cells are enriched in
the cirrhotic septa, especially in the scar tissue, and invade
the regenerating nodules. Both in humans and rats, Thy-1+
cells are typically portal stromal cells. The present in vitro
results demonstrate that, Thy-1+ cells represent populations
of portal Wbroblasts and myoWbroblasts, both in the human
and rat (Dudas et al. 2007). Expression of Thy-1 in endo-
thelial cells was detected in the border of the scar tissue of
the advanced human cirrhosis (Fig. 7). Thy-1 expression in
endothelial cells was rare. In our previous studies (Dudas
et al. 2007) utilizing northern blot-analysis, western blot-
analysis and immunocytochemistry, Thy-1-expression
could not be demonstrated in freshly isolated, or in culture-
activated HSC. In contrast, in vitro experiments proved at
mRNA and at protein levels that subcultured liver myoW-
broblasts represent a homogenous, uniform Thy-1+ cell
population. This Wnding in isolated rat liver cells has been
conWrmed in isolated and subcultured human liver myo-
Wbroblasts (Fig. 8). Sensitive methods utilizing real-time
RT-PCR and Xow cytometry detected Thy-1-expression, but
showed at least 20-times lower representation in HSC than
in rat liver myoWbroblasts. This Wnding might be due to a
contaminating population of MF, identiWed by Xow cytom-
etry (Dudas et al. 2007), but low-level expression of Thy-1
in HSC can not be excluded (see Fig. 7c). TGF1, IL-1 or
TNF cytokines do not induce Thy-1-expression in HSC
(data not shown). The same cytokines did not increase
Thy-1-gene-expression in MF.
In chronic rat liver injury the increased periportal
expression of Thy-1-reaction was associated with increased
expression of SMA and Gremlin (Supplementary Table
S1). In acute rat liver injury Thy-1 could not be demon-
strated in perisinusoidal cells. In this model of rat liver
injury local upregulation of inXammatory cytokines
(including IL-1, TNF- and IFN- can be demonstrated
6–24 h after the CCl4 administration (Sheikh et al. 2006),
while no sinusoidal Thy-1+ staining was observed. This
means that, inXammatory cytokines with the potential to
induce Thy-1 expression (demonstrated in endothelial cells
Fig. 5 Immunolocalization of Thy-1 and Gremlin in CCl4-induced
acute and chronic liver injury. ImmunoXuorescent stainings of Thy-1
(green) and Gremlin (red) after acute and chronic liver injury at indi-
cated time points after administration of CCl4, in the pericentral area
(left panels) and in the periportal area (right panels). On the lower pan-
els septal areas of cirrhotic livers (17 weeks after repeated treatment)
were represented. Co-localization of the two markers was labeled by
arrows. The blue staining with DAPI represents the nuclei (£200 orig-
inal magniWcation, bars 100 m)123
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Moreover, in vitro stimulation of 5 diVerent isolations of
HSC with TNF- both in the quiescent and activated
stages, did not lead to induction of Thy-1-gene-expression
(data not shown). In advanced stages of liver Wbrogenesis:
moderate Thy-1- Gremlin- and SMA- positivity can be
found in the portal sinusoids (Figs. 3, 5). Interestingly,
Thy-1+ and SMA+ (Gremlin+) reactions were separated,
apart from scattered dual immunoreactivity.
After PH, Thy-1 expression is present principally in peri-
portal localization. However, Thy-1+ cells can be also found
in the sinusoids, adjacent to the portal tract at 24 h after PH
(Fig. 6). Similarly to the Wndings of acute CCl4-induced
liver injury, Thy-1+ cells are not present in the pericentral
areas. After 24 h of PH, SMA-gene-expression decreases
(Figs. 2, 6), probably as a result of apoptosis of HSC (Saile
et al. 1997). The pattern of Thy-1 and SMA expression in
rat liver sinusoids 16–48 h after PH is diVerent. SMA has a
Fig. 6 Thy-1, Desmin and 
SMA in PH-induced rat liver 
regeneration. a ImmunoXuores-
cent labelings of Thy-1 (green) 
and Desmin (red) in rat liver 4, 
8, 24 and 48 h after PH, analyzed 
in the pericentral (left panels) 
and periportal spaces (right pan-
els). Periportally, Desmin partly 
co-localised with Thy-1, while 
Thy-1 was only sparsely present 
in the pericentral area. In the per-
icentral sinusoids the Desmin+-
reaction was not accompanied 
by Thy-1. Arrows: co-localiza-
tion of Thy-1 and Desmin. The 
blue staining with DAPI repre-
sents the nuclei, £200 original 
magniWcation, bars 100 m. b 
ImmunoXuorescent staining of 
Thy-1 (green) and SMA (red) in 
rat liver 4–48 h after PH. Thy-1 
was found mainly periportally, 
while SMA showed also a peris-
inusoidal localization (£200 
original magniWcation). The 
blue staining with DAPI repre-
sents the nuclei, bars 100 m, 
Arrows co-localization of Thy-1 
and SMA123
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contrast, Thy-1 is seen only in the sinusoids adjacent to the
portal tracts (zone 1) (Fig. 6). Periportal (zone 1) co-locali-
zation of Thy-1 and Desmin can be demonstrated readily,
but rarely in zone 3.
Based on the periportal localization of Thy-1+ cells in
normal, injured and regenerating liver, the portal Wbroblast
cell population is probably the principal source of the peri-
portal Thy-1-expressing cells in liver injury. We presume
that, periportal Thy-1+ myoWbroblasts migrate toward zone
3 along the sinusoids under conditions of liver injury.
Migration of liver myoWbroblasts has been described
recently via distinct pathways that signal through rho and
p38 MAP kinase (Rege et al. 2006; Tangkijvanich et al.
2003). Interestingly, endogenous or heterologous Thy-1
expression was found to promote focal adhesion and stress
Wber formation in isolated lung Wbroblasts, characteristic of
increased rho-GTPase activity, and inhibited migration
(Rege et al. 2006; Barker et al. 2004). Furthermore, also a
gene regulatory function was described for Thy-1. Two
genes, Fibronectin (FN) and Thrombospondin (TSP-1)
involved in cellular diVerentiation and the regulation of
tumor angiogenesis, respectively, were found to be up-regu-
lated upon Thy-1 induction (Abeysinghe et al. 2005). The
regulation of Fibronectin-gene-expression might be regu-
lated in a TGF-1 dependent pathway in hepatic stellate
cells (Knittel et al. 1996), and in a Thy-1 dependent path-
way in portal myoWbroblasts.
Although Thy-1 appears to be expressed in periportal
Wbroblasts and myoWbroblasts, the in vivo results of this
report demonstrate variability of Thy-1-gene-expression.
Previous reports suggest that Thy-1 may act as a cell
adhesion molecule. Data assists indicate that Thy-1 can
interact with integrins, but no speciWc ligand or counterre-
ceptor has been identiWed. In addition, lipids rafts, in
which GPI-anchored proteins, like Thy-1 are embedded,
are often the sites of formation of receptor-adhesion com-
plexes (Hudon-David et al. 2007). The fact that Thy-1+
and Thy-1¡ lung Wbroblasts behave diVerently suggests
that this protein may have a functional role (Koumas et al.
2003). Whether or not Thy-1 is responsible for a speciWc
action in a subpopulation of liver (myo)Wbroblasts
Fig. 7 Analysis of Thy-1, Desmin, SMA, vWF and Lyve-1 in human
liver cirrhosis. ImmunoXuorescent stainings of Thy-1 (green) (a–c),
Desmin (green) (a), SMA (red) (a, b) von Willebrand-factor (vWF)
(red) (a, b) and LYVE-1 (red) (c) in cirrhotic human liver samples.
Boxed areas in a are displayed at increased magniWcation in b. Solid ar-
rows indicate co-localization of Thy-1, Desmin and SMA. Arrowheads
indicate the co-localization of Thy-1 and vWF. Empty arrows show co-
localization of Thy-1 and Lyve-1. Negative controls were performed
by usage of isotype-matching mouse IgG and utilization of rabbit IgG.
The blue staining with DAPI represents the nuclei (a £100 original
magniWcation; b, c £200 original magniWcation, bars 100 m)123
Histochem Cell Biol (2009) 131:115–127 125Fig. 8 Analysis of Thy-1, SMA 
and Desmin in isolated human 
liver myoWbroblasts. Immuno-
Xuorescent stainings of SMA 
(green), Desmin (green) and 
Thy-1 (green) in isolated and 
passaged human liver myoWbro-
blasts. The blue staining with 
DAPI represents the nuclei, 
£200 original magniWcation, 
bars 100 m
Table 2 Comparison of hepatic stellate cells and liver myoWbroblasts, based on previous reports and the Wndings of this study
Hepatic stellate cells MyoWbroblasts
DeWnition Pericytes of the liver sinusoid Cells responsible for wound healing
Localization in the 
normal liver
Perisinusoidal Periportal, or located around the centrolobular 
vein, or in the liver capsule
Function in the 
normal liver
Vitamin A storage and regulation of retinoid metabolism, 
expression of matrix metalloproteinases (MMPs), 
matrix turnover (Knittel et al. 1999a)
Matrix production, tissue elasticity and resistance
Changes in liver injury Activation: loss of Vitamin A, SMA expression, 
matrix synthesis, expression of tissue 
metalloproteinase inhibitors
Activation: due to EDA-containing Fibronectin 
(Jarnagin et al. 1994), matrix synthesis, 
expression of tissue metalloproteinase inhibitors
Localization in the 
injured liver




Increase of cell volume




Increase of cell volume at late passages
High DNA and protein synthesis
Cell division
Inducible apoptosis
Markers Quiescent: Glial Fibrillary Acidic Protein, 
weak expression of Desmin, no Thy-1
Activated: Desmin, SMA, P100, Alpha-2-Macroglobulin, 
Reelin (Ogawa et al. 2007)
Synaptophysin (Cassiman and Roskams 2002)
No Thy-1
Thy-1, SMA, Desmin: only in subpopulations
Special matrix protein expression: Gremlin, 
Fibulin-2, Osteopontin (Ogawa et al. 2007)
Migration by chronic 
liver injury
Supposed: from sinusoids toward acinar zones 1 and 3 From portal scar tissue toward acinar zone 3
Thy-1 expression Not expressed, not induced Constitutive, no upregulation due to treatments 
with inXammatory cytokines
Extrahepatic sources According to recent publications is possible from the 
bone marrow (Miyata et al. 2008)
Reported from the bone marrow 
(Kisseleva et al. 2006)123
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Thy-1 may induce myoWbroblast migration along the liver
sinusoids.
In conclusion, Thy-1 is a functional marker of liver
(myo)Wbroblasts in normal, injured and regenerating rat
liver, and is located to zone 1 of the liver lobule. Culture-
activated HSC are comparable with perisinusoidal SMA+,
Vimentin+ (Geerts et al. 2001) Desmin,+ and Thy-1- cells in
vivo, which are located in zone 1 (Table 2). Neither basic
expression nor induction of Thy-1 could be demonstrated in
hepatic stellate cells in vivo. Scattered Thy-1+ sinusoidal
cells might be myoWbroblasts. Isolated human and rat liver
myoWbroblasts co-express Thy-1 and SMA.
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